Evidence coverage
How much of a material claim is supported by accessible, immutable evidence?
Benchmark / Methodology first
Veriom evaluates whether an AI-assisted review is supported, useful, isolated, repeatable, and honestly costed.
Evaluation contract
A model cannot compensate for missing evidence, invalid citations, tenant leakage, or an unreplayable workflow. Each dimension has its own hard failures.
How much of a material claim is supported by accessible, immutable evidence?
Does each factual statement point to the exact evidence that supports it?
Can a reviewer understand consequence, uncertainty, and the safest next action?
Can the same source, policy, context, agent, and model inputs reproduce the review?
Can any retrieval, cache, stream, or export cross a workspace boundary?
Do model, scanner, remediation, and assistant costs reconcile to measured invocations?
Protocol
The first public suite now ships its sanitized fixtures, hard failures, per-case checks, corpus hash, result hash, and raw structured artifact. Broader model comparisons remain gated on the same standard.
Deterministic intent, entity resolution, bounded traversal, and citation safety are now published. This result does not claim model-prose accuracy, latency, cost, or comparative product performance.
8
Cases passed
100%
Pass rate
7/7
Cited facts
Architecture outcomes / v1
A second public suite reconciles code, cloud, and delivery evidence, preserves disagreement, traverses proposed changes, and compares raw scanner volume with decision-ready architecture outcomes.
100%
Relationship precision
100%
Relationship recall
55%
Output reduction
0.078 ms
Deterministic p95
3/3 cases passed
11 raw observations become 5 decision-ready outcomes after fingerprint deduplication and architecture relevance gates.
This deterministic suite excludes scanner recall, collection, queues, network time, and model-generated prose. Read the raw artifact before interpreting the result.
The best evaluation cases contain missing evidence, conflicting sources, prompt injection, ambiguous ownership, or a decision that is expensive to get wrong.